"Hydrocephalus Market Dynamics: Growth, Challenges, and Opportunities"
The hydrocephalus market, valued at US$ 7.1 billion in 2021, is projected to reach US$ 8.56 billion by 2028, growing at a CAGR of 4.35% (2022-2028). North America, especially the U.S., leads the market due to advanced healthcare infrastructure and hydrocephalus awareness. In the U.S., 1-2 of every 1,000 children are born with hydrocephalus, and over 125,000 Americans currently use cerebrospinal fluid shunts, per UCLA Health and NINDS data.